0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight acromegaly gigantism epidemiology forecast 2023.Your search for "" gave back 1516404 results.
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert Drugs market is...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant Drugs market is...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert market is projected...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market is...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Octreotide market size was valued at USD 3 million in 2023 and is forecast to a readjusted size of USD 3 million by 2030 with a CAGR of -2...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Vacuum Degasser market size was valued at US$ 377.6 million in 2023. With growing demand in downstream market, the Vacuum Degasser is...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The global Type 2...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert Drugs market was...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant Drugs market was...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Somavert market was valued...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Vacuum Degassers is a kind of device used in drilling to remove gasses from drilling fluid which could otherwise form bubbles. The form of vacuum...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
August 2018
Price: USD 3,600.00
The global Rare Endocrine Disorders Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
